CSIMarket
 


Immunic Inc   (IMUX)
Other Ticker:  
 
 

IMUX's EPS from Cont. Operations Growth by Quarter and Year

Immunic Inc 's EPS from Cont. Operations results by quarter and year




IMUX EPS from Cont. Operations (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December -1.47 -0.80 -0.54 -0.26
III Quarter September -0.69 -0.76 -0.70 -0.82
II Quarter June -0.72 -0.82 -0.90 -1.52
I Quarter March -0.74 -1.63 -0.79 -0.22
FY   -3.62 -4.01 -2.93 -2.82



IMUX EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Comment
Immunic Inc in the fourth quarter 2022 recorded EPS loss from Cont. Operations of $ -1.47 .

According to the results reported in the fourth quarter 2022, Immunic Inc achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Immunic Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the fourth quarter 2022.




IMUX EPS from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Immunic Inc 's fourth quarter 2022 EPS from Cont. Operations $ -1.47 IMUX's Income Statement
Immunic Inc 's fourth quarter 2021 EPS from Cont. Operations $ -0.80 Quarterly IMUX's Income Statement
New: More IMUX's historic EPS from Cont. Operations Growth >>


IMUX EPS from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Immunic Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's IV. Quarter Q/Q EPS from Cont. Operations Comment
Current EPS loss from Cont. Operations of -1.47 by Immunic Inc appear even less good if you take a look at -0.69 a quarter before.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential EPS from Cont. Operations growth. While Immunic Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's IV. Quarter Q/Q EPS from Cont. Operations Comment
Recent accomplishment of -1.47 by Immunic Inc come out even worse if you take a look at -0.69 in the third quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential EPS from Cont. Operations growth. While Immunic Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Immunic Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ -3.62 $ -2.95 $ -3.02 $ -3.12 $ -4.01
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment


Immunic Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment


Immunic Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
IMUX's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for IMUX's Competitors
EPS from Cont. Operations Growth for Immunic Inc 's Suppliers
EPS from Cont. Operations Growth for IMUX's Customers

You may also want to know
IMUX's Annual Growth Rates IMUX's Profitability Ratios IMUX's Asset Turnover Ratio IMUX's Dividend Growth
IMUX's Roe IMUX's Valuation Ratios IMUX's Financial Strength Ratios IMUX's Dividend Payout Ratio
IMUX's Roa IMUX's Inventory Turnover Ratio IMUX's Growth Rates IMUX's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2022
Community Health Systems Inc 130.73%$ 130.726 
Cadre Holdings Inc 119.80%$ 119.799 
Semler Scientific Inc 115.62%$ 115.619 
Molecular Templates inc 115.27%$ 115.272 
Harmony Biosciences Holdings inc 110.28%$ 110.282 
Fonar Corporation100.00%$ 100.000 
Avanos Medical Inc 77.98%$ 77.981 
Amphastar Pharmaceuticals Inc 69.98%$ 69.979 
Chemomab Therapeutics Ltd 66.87%$ 66.867 
Repligen Corp66.09%$ 66.085 
Avantor Inc 64.49%$ 64.492 
Merit Medical Systems Inc60.32%$ 60.322 
Medpace Holdings Inc 58.64%$ 58.641 
Singular Genomics Systems Inc 53.66%$ 53.657 
Biogen Inc 52.60%$ 52.603 
Boston Scientific Corporation50.00%$ 50.000 
Pfizer Inc47.13%$ 47.133 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com